PATENT CLAIM ANALYSIS

Application Number: 15747220
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["514", "210200"]

Abstract:
The present invention relates to amide derivatives having dual pharmacological activity towards both the sigma (σ) receptor, and the μ-opioid receptor, to processes of preparation of such compounds, to pharmaceutical compositions comprising them, and to their use in therapy, in particular for the treatment of pain.

Claim (Index 41):
The method according to  claim 40 , wherein the pain is selected from the group consisting of medium to severe pain, visceral pain, chronic pain, cancer pain, migraine, inflammatory pain, acute pain, neuropathic pain, allodynia, and hyperalgesia.

Metadata:
- Claim Count in Document: 74.0
- Percentile: 86.0
- Lexical Diversity: 1.35
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15746877', '15531810', '15571352', '16090403', '15315486']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8661398708180889
- 35 USC 102 Novelty (BERT): 0.5712071899207863
- Combined Prediction Score: 0.8366466027283586
- Mean Citation Score: 484.095566
- Max Citation Score: 527.3969
- Similarity Product: 362.9698225286842

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test